Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IseeG

Financiado

Cerrado

FunctIonal optoacousticS for imaging Early onsEt of Gut inflammation

"The aim of this project is to functionalize contrast agents for multispectral optoacoustic tomography (MSOT) - a molecular ""sensitive"" ultrasound imaging technique - to develop a new targeted imaging approach for the early loca... ver más

30/11/2028

Universitätsklinik...

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

UNIVERSITATSKLINIKUM ERLANGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-20

ERC-2023-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Universitätsklinikum Erlange...

1.45M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PREMSOT Precision Multi Spectral Optoacoustic Tomography for Discove... 2M€ Cerrado

EMSOT Endoscopic Multi Spectral Optoacoustic Tomography 165K€ Cerrado

EUPHORIA Enhancing Ultrasound and PHOtoacoustics for Recognition of I... 3M€ Cerrado

MSOT Quantitative real time multi spectral optoacoustic tomograph... 161K€ Cerrado

WINTHER Fast optoacoustic mesoscopy using the skin as a window for... 5M€ Cerrado

DYNAMIT Deep Tissue Optoacoustic Imaging for Tracking of Dynamic Mol... 1M€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2023-11-20
Fecha Fin: 2028-11-30

Líder del proyecto

UNIVERSITATSKLINIKUM ERLANGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "The aim of this project is to functionalize contrast agents for multispectral optoacoustic tomography (MSOT) - a molecular ""sensitive"" ultrasound imaging technique - to develop a new targeted imaging approach for the early localisation of inflammatory processes. Inflammatory processes in the gastrointestinal tract often act like a Trojan horse - while camouflaging themselves with diffuse clinical symptoms, they may rapidly progress into life-threatening complications. To date, it has been difficult to precisely localize them in their early stages, and their detection remains the domain of invasive endoscopy. The invasive nature of this method not only restricts its use for early disease detection, but is a major limitation for repetitive or high-risk applications. MSOT uses laser light excitation and ultrasound detection to resolve different chromophores such as haemoglobin, lipids, and other metabolic parameters at depths of several centimetres. While we were using the response from endogenous chromophores for translational to a range of potential clinical applications, we discovered that dyes delivered via the oral route enable the dynamic visualization of the entire intestinal tract. This molecular-sensitive approach has the advantage that such contrast agents are not absorbed systemically and undergo excretion largely unchanged. Based on this, I hypothesize that it is possible to functionalize such contrast agents in order to put a molecular flag on inflamed areas in the gastrointestinal tract. After characterizing potential imaging targets in the intestinal lumen and developing imaging agents, we will take a translational research approach, moving from cells through small and large experimental animal models back to the human system. This research at the frontiers of medicine and physics may pave the way to non-invasive early detection and personalized treatment strategies while minimizing the procedural risk for affected patients."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores